Showing 981 - 1,000 results of 1,474 for search 'obstructive changes', query time: 0.11s Refine Results
  1. 981

    The clinical significance of iron metabolism disorders in patients with high activity of rheumatoid arthritis by E. A. Galushko, A. S. Semashko, A. M. Lila

    Published 2024-06-01
    “…In the same subgroup, one in ten had a change of two classes of bDMARDs/tsDMARDs by the time of the study.Conclusion. …”
    Get full text
    Article
  2. 982
  3. 983
  4. 984
  5. 985

    FUNCTIONAL RESPONSE TO ENDOBRONCHIAL VALVE IMPLANTING TO THOSE SUFFERING FROM PULMONARY DESTRUCTIVE TUBERCULOSIS by L. A. Popova, E. A. Shergina, O. V. Lovacheva, T. R. Bagdasaryan, N. A. Chernykh, V. B. Nefedov

    Published 2016-09-01
    “…Reduction of pulmonary ventilation capacity due to large bronchi obstruction, restrictive changes and pulmonary gas exchange were manifested through reduction of FEV1 in 18.9% (95% CI 11.6-29.3%) of patients, PEF – in 20.3% (95% CI 12.7-30.8%), VC – in 22.9% (95% CI 14.9%-33.8%) and PaO2 – in 32.4% (95% CI 22.9-43.7%) of patients.Reduction of carbonic acid content in blood was observed in 27.0% (95% CI 18.3-38.1%) of patients. …”
    Get full text
    Article
  6. 986
  7. 987

    Criteria for the duration of anti-inflammatory therapy in children with bronchopulmonary dysplasia by Т. І. Stepanenko, I. M. Khrystosova, H. V. Rukavytsia

    Published 2019-04-01
    “…Capnographic changes remained longer (from 3 to 12 months). Chest radiographs showed changes within a period from 9 to 12 months and these changes did not always correspond to the symptoms resolution. …”
    Get full text
    Article
  8. 988

    Disease burden of COPD attributable to PM2.5 in China, Japan and South Korea from 1990 to 2019: a comparative study based on Global Burden of Disease Study 2019 by Bei Li, Xiao-Fen Cheng, Shu-Hui Min, Rui-Qi Guo, Jin-Dan Zhang, Yi-Li Zhang

    Published 2024-02-01
    “…Objective We hope to reveal the changing trends of chronic obstructive pulmonary disease (COPD) burden attributable to particulate matter pollution (PM2.5) and its age, period and cohort effects in China, Japan and Korea.Design We analysed the trend of COPD disease burden attributable to PM2.5 from 1990 to 2019 based on the latest Global Burden of Disease Database (GBD 2019) using JoinPoint model and analysed the effect of age, period and cohort on COPD burden attributable to PM2.5 in China, Japan and Korea from 1990 to 2019 using age-period-cohort model (model).Setting GBD data from 1990 to 2019.Participants Data were publicly available and individuals were not involved.Main outcomes Outcomes included the age standardised mortality rate (ASMR), the age-standardised disability-adjusted life year (DALY), average annual per cent change (AAPC), net drift, local drift, longitudinal age curves, period (cohort) rate ratios, age (period, cohort) bias coefficient.Results From 1990 to 2019, the ASMR of COPD attributable to PM2.5 in China (AAPC=−5.862), Japan (AAPC=−1.715) and Korea (AAPC=−1.831) showed a downward trend. …”
    Get full text
    Article
  9. 989

    A descriptive analysis of rural seniors with femur and pelvis fractures and the impact of morphine milliequivalents on inpatient rehabilitation by Rabah Boukemis, Robert Jackson, Erin Shaver, Ransom Chafin, Chris Fitzpatrick, Adam M. Franks, Courtney D. Wellman

    Published 2025-06-01
    “…Results: Of the studied ≥65-year-old patients (n = 115), the amount of MME weakly positively correlated, with the change in GG score for MME/day (P = 0.01), mobility (P = 0.02) and self-care (P = 0.03) scores. …”
    Get full text
    Article
  10. 990

    Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protoc... by Bjorn Winkens, Esther A. Boudewijns, Danny Claessens, Manuela Joore, Lotte C.E.M. Keijsers, Onno C.P. van Schayck, Annerika H.M. Gidding-Slok

    Published 2020-11-01
    “…The present paper documents a protocol for a quasi-experimental study investigating the effectiveness and cost-effectiveness of the ABCC tool for people with chronic obstructive pulmonary disease, asthma, type 2 diabetes mellitus and/or heart failure.Methods and analysis The study has a pragmatic clustered quasi-experimental design and will be conducted in the Netherlands. …”
    Get full text
    Article
  11. 991

    Identifying Concepts of Physical Activity Which Are Clinically Meaningful to Patients and Care Providers: A Systematic Review of Qualitative Research by Candice Taguibao, Salma Ajraoui, Jake Centra, Kieran F. Reid, Christina Daskalopoulou, Alberto Conde Freniche, Alan L. Hamilton, Astrid M. H. Horstman, Benjamin X. Collins, Jessilyn Dunn, Elena S. Izmailova

    Published 2025-04-01
    “…Conditions covered included Parkinson's disease, multiple sclerosis, chronic obstructive pulmonary disease, cancer, Duchenne muscular dystrophy, chronic heart failure, sickle cell disease, osteoarthritis, and sarcopenia. …”
    Get full text
    Article
  12. 992

    PRDM16 acts as a homeostasis regulation factor to suppress the transition of AKI to CKD via upregulation of eukaryotic initiation factor 6 by Xiaozhou Li, Yang Xia, Xingjin Li, Yong Guo, Shuangfa Qiu, Huiling Li, Yijian Li, Lidong Wu, Dongshan Zhang

    Published 2025-06-01
    “…Finally, the PRDM16/eIF6/Wnt/β-catenin/SP1/TGF-β, CTGF, and NLRP3 axis were analyzed in renal biopsies from individuals with minimal change disease and severe obstructive nephropathy. …”
    Get full text
    Article
  13. 993
  14. 994

    Advances in CT coronary angiography-derived plaque analysis for comprehensive assessment of ischemic heart disease by Cozac Dan-Alexandru, Lassandro Eleonora, Savo Maria Teresa, Cordoni Gabriele, Tansella Donatella, Motta Raffaella, Pergola Valeria

    Published 2025-03-01
    “…The advancement of CCTA-derived plaque analysis represents a significant change in cardiovascular imaging, enhancing diagnostic precision and risk assessment. …”
    Get full text
    Article
  15. 995

    Sacral Neuromodulation Treatment for Non-neurogenic Urological Disorders: Experience of a Single Center in Turkey by Adem Emrah Coğuplugil, Sercan Yılmaz, Bahadır Topuz, Murat Zor, Engin Kaya, Mesut Gürdal

    Published 2021-12-01
    “…Objective:We evaluated the success rate and complications of sacral neuromodulation (SNM) in patients with non-neurogenic urological disorders.Materials and Methods:We retrospectively evaluated patients with an overactive bladder (OAB), bladder pain syndrome/interstitial cystitis (BPS/IC), and idiopathic non-obstructive urinary retention (IUR), who underwent SNM between 2015 and 2020. …”
    Get full text
    Article
  16. 996
  17. 997

    Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc R... by Kai-Michael Beeh, Karl Scheithe, Heike Schmutzler, Saskia Krüger

    Published 2025-07-01
    “…Post hoc responder analyses for CAT (≥ 2 units improvement), FEV1 (≥ 100 ml change), and exacerbations (no event) were performed. …”
    Get full text
    Article
  18. 998
  19. 999
  20. 1000

    Characteristics of Older Individuals with Asthma Being Treated with Biologics by Aetou M, Kiskinov Y, Ratsimba SFN, Barth M, Pizarro C, Bergs I, Spiesshoefer J, Skowasch D, Dreher M

    Published 2025-06-01
    “…Baseline lung function parameters, and the change in lung function after 6 months of biologic therapy, did not differ significantly between the two age groups. …”
    Get full text
    Article